Reduction of myocardial ischemic injury and left ventricular dysfunction by vasodilator therapy.
D000818:Animals; D003327:Coronary Disease / Q000209:etiology / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy; D006352:Heart Ventricles / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*
D014665:Vasodilator Agents